Skip to main content
CellSeed Inc. logo

CellSeed Inc. — Investor Relations & Filings

Ticker · 7776 ISIN · JP3423530009 T Manufacturing
Open in API
Filings indexed 69 across all filing types
Latest filing 2026-06-01 Share Issue/Capital Cha…
Country JP Japan
Listing T 7776

About CellSeed Inc.

https://www.cellseed.com/en/

CellSeed Inc. is a regenerative medicine company centered on the research, development, and commercialization of its proprietary "cell sheet engineering" technology. This innovative platform enables the creation and harvesting of intact sheets of cultured cells without enzymatic treatment, preserving the extracellular matrix and cell-to-cell junctions critical for therapeutic efficacy. The company's business is structured around three core activities: the development of its own pipeline of cell sheet-based therapies for tissue regeneration, the sale of specialized temperature-responsive cell cultureware and related equipment, and the provision of contract development and manufacturing (CDMO) services for regenerative medicine products.

Recent filings

Filing Released Lang Actions
第25回新株予約権（行使価額修正条項付）の月間行使状況に関するお知らせ
Share Issue/Capital Change Classification · 95% confidence The document is a monthly exercise status announcement for the company’s 25th series stock acquisition rights (warrants), detailing the number of warrants exercised, remaining unexercised warrants, and related capital issuance figures. This falls under announcements of capital changes (new share issuance via warrant exercise). Therefore, it is classified as a Share Issue/Capital Change (SHA).
2026-06-01 Japanese
第26回新株予約権（無償ストック・オプション）の発行内容確定に関するお知らせ
Share Issue/Capital Change Classification · 85% confidence The document is an official announcement by CellSeed regarding the finalized terms for issuing their 26th series of stock acquisition rights (free stock options) to directors and employees. It details the number of options, allocation, exercise terms, and related share quantities. This is a capital issuance event (new stock option issuance), matching the Share Issue/Capital Change category (SHA).
2026-05-18 Japanese
第25回新株予約権（行使価額修正条項付）の月間行使状況に関するお知らせ
Regulatory Filings
2026-05-01 Japanese
第26回新株予約権（無償ストック・オプション）の発行に関するお知らせ
Regulatory Filings
2026-04-14 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references the Financial Instruments and Exchange Act (金融商品取引法). It serves as an officer certification confirming the accuracy of the company's Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 25
2026-03-26 Japanese
有価証券報告書－第25期(2025/01/01－2025/12/31)
Annual Report Classification · 100% confidence The document is a Japanese '有価証券報告書' (Yuuka Shouken Houkokusho), which is the standard Japanese equivalent of an Annual Report (10-K). It contains detailed financial statements, business indicators, and management information for the fiscal year ending December 31, 2025. It is not an announcement or a summary, but the full regulatory filing itself. FY 2025
2026-03-26 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.